human pluripotent stem cell registry - hPSCreg

HealthHORIZON-CSAID: 101074135
EC Contribution
€14,993
Consortium Size
1 orgs
Start Year
2022
Summary

The human pluripotent stem cell registry (hPSCreg) is providing validated information about human embryonic stem cells (ESC) and other human pluripotent stem cells (PSC) such as induced PSC. This information is linked through an unique persistent identifier and it includes data on ethical provenance and scientific quality, cell line application and clinical studies performed with hPSC. The open access Registry acts globally to provide a transparent resource and tool for PSC, to maximize cell utility, reproducibility and benefit and minimize research, ethical and regulatory risks. It validates and certifies the registered cell lines based on the provided documents, data and information, assuring high quality of certified lines. hPSCreg is involved in multiple EU-Projects, international consortia and organizations to provide information, data standards and support dissemination. The main task of hPSCcreg within this project proposal are to maintain and improve its function as a centralized registry of hESC and hiPSC lines allowing for (i) transparent validation and monitoring of the ethical and scientific developments in the field; (ii) transparent data – based certification of PSC to assure and maintain highest quality; (iii) implementing FAIR data standards and a continuously improved data reliability in downstream stem cell research; (iv) supporting academic, industrial and clinical research on PSCs and maximizing their potential; and (v) inclusion of diverse stakeholders in the communication process on emerging PSC - based technologies, including research towards clinical applications.

Consortium (1)

Project Results (19)

Source: CORDIS, the EU research results database.

Publications (5)
A Standardized Nomenclature Design for Systematic Referencing and Identification of Animal Cellular Material
Animals· 2025DOI
Lisa Schrade, Nancy Mah, Anita Bandrowski, Ying Chen, Johannes Dewender, Sebastian Diecke, Christian Hiepen, Madeline A. Lancaster, Tomas Marques-Bonet, Sira Martinez, Sabine C. Mueller, Christopher Navara, Alessandro Prigione, Stefanie Seltmann, Jaroslaw Sochacki, Magdalena A. Sutcliffe, Vera Zywitza, Thomas B. Hildebrandt, Andreas Kurtz
Dynamic governance: A new era for consent for stem cell research
Stem Cell Reports· 2024DOI
Rosario Isasi, Heidi B. Bentzen, Morris Fabbri, Antonie Fuhr, Joel C. Glover, Nancy Mah, Deborah Mascalzoni, Sabine Mueller, Stefanie Seltmann, Andreas Kurtz
Guidelines for managing and using the digital phenotypes of pluripotent stem cell lines
Stem Cell Reports· 2024DOI
Christine A. Wells, Anke Guhr, Amos Bairoch, Ying Chen, Mengqi Hu, Peter Löser, Tenneille E. Ludwig, Nancy Mah, Sabine C. Mueller, Andrea E.M. Seiler Wulczyn, Stefanie Seltmann, Bella Rossbach, Andreas Kurtz
History and current status of clinical studies using human pluripotent stem cells
Stem Cell Reports· 2023DOI
4. Kobold S, Bultjer N, Stacey G, Mueller SC, Kurtz A, Mah N
Human pluripotent stem cell registry: Operations, role and current directions
Cell Proliferation· 2022DOI
7. Kurtz A, Mah N, Chen Y, Fuhr A, Kobold S, Seltmann S, Müller SC.
Deliverables (13)
Other Results (1)
Periodic Reporting for period 2 - hPSCreg (human pluripotent stem cell registry - hPSCreg)